Log in to save to my catalogue

Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian...

Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37496e400f5a4d62b9bebdde96a95491

Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study

About this item

Full title

Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2022-06, Vol.12 (1), p.10882-10, Article 10882

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Extended infusion of piperacillin/tazobactam over 4 h has been proposed as an alternate mode of administration to the 30-min intermittent infusion to optimize treatment effects in patients with gram-negative bacterial infections. The study aimed to evaluate the extended infusion regimen of piperacillin/tazobactam in standings of efficacy, safety, a...

Alternative Titles

Full title

Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_37496e400f5a4d62b9bebdde96a95491

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_37496e400f5a4d62b9bebdde96a95491

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-022-12861-7

How to access this item